NewsNovo
Medicare beneficiaries will gain access to GLP-1 weight-loss drugs for the first time beginning July 1, a historic policy shift that brings millions of older Americans into a coverage category previously closed to them.
The change marks a meaningful expansion of what the program will pay for, and it arrives with a set of considerations that are specific to this population.
A Coverage First, Not a Simple Unlock For years, Medicare explicitly excluded coverage of drugs prescribed solely for weight loss.
The program will now cover GLP-1 medications for weight management, placing older Americans alongside other covered populations for the first time.
Keep reading